News

AVANT BIO and Portfolio Company Intrepid Labs Nominated for 2025 Prix Galien USA Awards

AVANT BIO is honored to announce that we have been nominated for the 2025 Prix Galien USA Award in the “Incubators, Accelerators, & Equity” category. Adding to this distinction, our portfolio company Intrepid Labs has also been nominated in the “Best Startup” category, a rare occurrence for both an investment fund and a portfolio company to be recognized in the same year.

The Prix Galien Awards, established in 1970, are among the most prestigious honors in life sciences, celebrating global excellence and innovation. AVANT BIO’s nomination underscores our focus on enabling technologies that accelerate the discovery, development, and manufacturing of tomorrow’s therapeutics.

Winners will be announced at the Prix Galien USA Awards Gala in New York this October, following the Galien Forum.

Read the press release